Tech led — narrowly
Tech-adjacent leadership held, but it wasn’t “index up, everything up.” Money crowded into a small set of story-plus-numbers names where operating leverage is visible and the time horizon is long enough to justify paying up.
Micron (MU) was the clearest momentum expression: roughly +$200B in market cap over the past week, its best week in 20 years, ending the week valued above JPMorgan. That’s less a macro call than a positioning trade around AI/data-center scarcity, tight supply, and the market rewarding anyone who can credibly be a bottleneck in the stack.
Rocket Lab (RKLB) climbed back to record highs without needing a single headline. Execution plus a long runway keeps getting underwritten, and “innovation beta” still works when the tape wants offense—but only in names investors can hold through a drawdown.
In software/platform land, Toast (TOST) delivered what this market demands: a margin framework you can model. Guidance came in at FY2026 adjusted EBITDA of $790M–$810M with 21%–23% recurring gross profit growth. That’s the kind of setup where multiple support comes from something sturdier than vibes.
The common thread: the bid is alive, but you have to earn it with either (1) AI-linked supply leverage (MU), (2) credible long-duration execution (RKLB), or (3) a profitability path you don’t need to squint to believe (TOST).
“Self-help” bids
Outside the leaders, the more durable buying showed up in companies putting hard rails around the forward story—guidance bands, capital return, or a shift toward less variable revenue.
ANI Pharmaceuticals (ANI) moved higher after raising 2026 revenue to $1.08B–$1.14B and announcing a $100M share repurchase. “Raise + buyback” is still the simplest language this market responds to: better visibility, plus capital discipline.
Terawulf laid out a capacity plan to 480 MW operational capacity by 2H 2027 and leaned into a pivot toward contracted HPC revenue. Investors are trying to separate commodity-ish exposure from something financeable. Contracting is the attempt to turn a cyclical profile into one you can underwrite with a spreadsheet instead of a weather app.
A couple smaller items that still matter:
- Nephros expects 10% tariff relief in 2026 to support margins. Cost levers beat demand promises in this part of the cycle.
- NewLake said 50%–55% of base rent comes from medical cannabis tenants and discussed steps toward a major exchange listing. Tenant mix and listing eligibility are real valuation variables, even if they don’t make for great copy.
When macro is noisy, narratives work better with guardrails. The market will buy stories—it just charges more for them.
Macro split, dispersion wide
The data didn’t settle the soft-landing argument; it widened it. Nonfarm payrolls rose by more than the expected +55,000 in April (the sheet didn’t include the absolute print), so the labor side still looks intact.
Consumers look like they’re reacting to a different set of inputs. University of Michigan early May consumer sentiment hit a record low, with pessimism especially pronounced among Republicans. The sheet flagged surging gas prices in early May as a driver, and that’s the point: gasoline hits fast, it’s visible, and it can reset inflation psychology before slower-moving measures have time to win the argument.
Energy stayed mostly background—until it isn’t:
- Venezuela enacted emergency stabilization measures after electricity usage hit a nine-year high.
- ECB’s Joachim Nagel said the ECB is “highly vigilant” on inflation and ready to act if energy costs bleed through.
Rates chatter leaned toward 2026 Fed cuts rather than imminent easing, which fits a tape where jobs are okay, confidence is not, and energy can swing expectations quickly.
Dispersion did the rest. Odyssey (ODSY) and Mobia (MBIA)raised $454M combined but slid after their IPO debuts. Deals are getting done, but public buyers still want a reason to own the paper at the offering price. BuzzFeed (BZFD) stayed under pressure after an extension to May 18 on a $5M debt payment, alongside going-concern warnings. Weak balance sheets aren’t getting patience; they’re getting deadlines.
Policy and trade stayed in the noise: Canada moved consultations toward a one-year review timeline for major project approvals, and Trump is expected to seek new tariffs after a court blocked the latest plan. Track it for margins and supply chains, but it didn’t drive the tape.
The market is paying for certainty—either in earnings power, in contracts, or in capital structure. Everything else is renting attention.